MIM Pharma’s research & development started in 2013 with brilliant and distinguished researchers with backgrounds from high-ranked US, Germany, Iran and Norway universities with very rich industrial experience conducted research and development in migraine and migraine-related diseases.
With our innovative and insightful technology, using the System Biology approach, MIM Pharma is applying advanced machine learning and natural language processing (NLP) techniques to help our researchers, engineers and clinicians perform their work even more effectively.
We strive to transfer the legacy of deep-rooted natural medicine to the modern pharmaceutical R&D and manufacturing techniques for introducing NOVEL medical solutions. In order to provide excellent solutions, we dedicate time and resources to help humanity by developing treatment and cures for COVID-19, Migraine and migraine-related diseases. Our highly skilled team of biochemists, engineers, and programmers working tirelessly to bring MIM Pharma to the forefront of the industry.
To transfer the legacy of deep-rooted-natural medicine to the modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions
To help humanity get rid of common and widespread ailments such as Covid-19 and migraine headaches.
To be an R&D-oriented pharmaceutical company by applying the most up-to-date technology, techniques, and quality
To introduce novel medical solutions to the world
To remove or mitigate pain and ailments using natural solutions.
To create a scientific, energetic, and entrepreneurial organization that contributes to the improvement of improving human health
To emphasize on innovation and continuous improvement both in the processes and medical solutions
To commit to the well-being of mankind, especially the patients
To act ethically and treat all with honesty and respect
Brilliant and distinguished researchers with very rich backgrounds from high-ranked US, Germany, Iran, and Norway universities with very rich industrial experience.